Protalix Biotherapeutics Stock Market Outlook
| PLX Stock | USD 2.73 0.39 16.67% |
Slightly above 59% of all Protalix Biotherapeutics' investors are looking to take a long position. The analysis of the overall investor sentiment regarding Protalix Biotherapeutics suggests that some traders are interested. Protalix Biotherapeutics' investing sentiment can be driven by a variety of factors including economic data, Protalix Biotherapeutics' earnings reports, geopolitical events, and overall market trends.
Comfort Level 59
Interested
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Protalix Biotherapeutics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Protalix Biotherapeutics.
News SentimentBullish | Hype SentimentBullish | Insider SentimentWaiting |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Protalix Biotherapeutics is 'Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Protalix Biotherapeutics given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Protalix Biotherapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Execute Protalix Biotherapeutics Advice
The Protalix recommendation should be used to complement the investment advice compiled from the current analysts' consensus on Protalix Biotherapeutics. Macroaxis does not own or have any residual interests in Protalix Biotherapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Protalix Biotherapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Mild | Details | |
Volatility | Relatively risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Tiny | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
For the selected time horizon Protalix Biotherapeutics has a Mean Deviation of 2.58, Semi Deviation of 3.33, Standard Deviation of 3.6, Variance of 12.97, Downside Variance of 12.75 and Semi Variance of 11.12We provide trade recommendations to complement the recent expert consensus on Protalix Biotherapeutics. Our dynamic recommendation engine exercises a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time. To make sure Protalix Biotherapeutics is not overpriced, please check all Protalix Biotherapeutics fundamentals, including its current ratio, and the relationship between the gross profit and target price . Please also confirm Protalix Biotherapeutics number of shares shorted to check out your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.
Protalix Biotherapeutics Trading Alerts and Improvement Suggestions
| Protalix Biotherapeutics had very high historical volatility over the last 90 days | |
| Latest headline from finance.yahoo.com: Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio in the EU |
Protalix Biotherapeutics Returns Distribution Density
The distribution of Protalix Biotherapeutics' historical returns is an attempt to chart the uncertainty of Protalix Biotherapeutics' future price movements. The chart of the probability distribution of Protalix Biotherapeutics daily returns describes the distribution of returns around its average expected value. We use Protalix Biotherapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Protalix Biotherapeutics returns is essential to provide solid investment analysis for Protalix Biotherapeutics.
| Mean Return | 0.04 | Value At Risk | -4.64 | Potential Upside | 4.02 | Standard Deviation | 3.60 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Protalix Biotherapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Protalix Biotherapeutics Cash Flow Accounts
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Change In Cash | 20.7M | (21.9M) | 6.5M | (3.9M) | (3.5M) | (3.3M) | |
| Free Cash Flow | (11.7M) | (25.6M) | (2.5M) | 7.4M | 6.7M | 7.0M | |
| Other Non Cash Items | 3.9M | (1.2M) | (638K) | 138K | 158.7K | 166.6K | |
| Capital Expenditures | 1.5M | 628K | 1.1M | 1.3M | 1.5M | 1.5M | |
| Net Income | (27.6M) | (14.9M) | 8.3M | 2.9M | 2.6M | 2.8M | |
| End Period Cash Flow | 39.0M | 17.1M | 23.6M | 19.8M | 22.7M | 31.4M | |
| Depreciation | 1.1M | 1.1M | 1.2M | 1.3M | 1.5M | 2.0M | |
| Change To Inventory | (4.9M) | 1.2M | (2.2M) | (2.2M) | (2.0M) | (2.1M) | |
| Change To Netincome | 835K | 2.8M | 3.6M | 556K | 639.4K | 607.4K | |
| Investments | 18.9M | (5.0M) | (16.7M) | 4.2M | 3.8M | 4.0M |
Protalix Biotherapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Protalix Biotherapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Protalix Biotherapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Protalix stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.01 | |
β | Beta against Dow Jones | 0.87 | |
σ | Overall volatility | 4.17 | |
Ir | Information ratio | -0.0052 |
Protalix Biotherapeutics Volatility Alert
Protalix Biotherapeutics shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Protalix Biotherapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Protalix Biotherapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Protalix Biotherapeutics Fundamentals Vs Peers
Comparing Protalix Biotherapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Protalix Biotherapeutics' direct or indirect competition across all of the common fundamentals between Protalix Biotherapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Protalix Biotherapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Protalix Biotherapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Protalix Biotherapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Protalix Biotherapeutics to competition |
| Fundamentals | Protalix Biotherapeutics | Peer Average |
| Return On Equity | 0.13 | -0.31 |
| Return On Asset | 0.0553 | -0.14 |
| Profit Margin | 0.09 % | (1.27) % |
| Operating Margin | 0.12 % | (5.51) % |
| Current Valuation | 187.9 M | 16.62 B |
| Shares Outstanding | 80.42 M | 571.82 M |
| Shares Owned By Insiders | 10.15 % | 10.09 % |
| Shares Owned By Institutions | 17.90 % | 39.21 % |
| Number Of Shares Shorted | 4.55 M | 4.71 M |
| Price To Earning | (1.23) X | 28.72 X |
| Price To Book | 3.56 X | 9.51 X |
| Price To Sales | 3.38 X | 11.42 X |
| Revenue | 53.4 M | 9.43 B |
| Gross Profit | 35.58 M | 27.38 B |
| EBITDA | 6.52 M | 3.9 B |
| Net Income | 2.93 M | 570.98 M |
| Cash And Equivalents | 19.76 M | 2.7 B |
| Cash Per Share | 0.41 X | 5.01 X |
| Total Debt | 5.53 M | 5.32 B |
| Current Ratio | 1.33 X | 2.16 X |
| Book Value Per Share | 0.66 X | 1.93 K |
| Cash Flow From Operations | 8.67 M | 971.22 M |
| Short Ratio | 5.66 X | 4.00 X |
| Earnings Per Share | 0.08 X | 3.12 X |
| Price To Earnings To Growth | (0.10) X | 4.89 X |
| Target Price | 11.0 | |
| Number Of Employees | 213 | 18.84 K |
| Beta | -0.22 | -0.15 |
| Market Capitalization | 209.1 M | 19.03 B |
| Total Asset | 73.42 M | 29.47 B |
| Retained Earnings | (378.39 M) | 9.33 B |
| Working Capital | 34.46 M | 1.48 B |
| Current Asset | 59.65 M | 9.34 B |
Note: Acquisition by Shaaltiel Yoseph of 122162 shares of Protalix Biotherapeutics at 0.001 subject to Rule 16b-3 [view details]
Protalix Biotherapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Protalix . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Protalix Biotherapeutics Buy or Sell Advice
When is the right time to buy or sell Protalix Biotherapeutics? Buying financial instruments such as Protalix Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Protalix Biotherapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Education Thematic Idea Now
Education
Companies involved in apprenticeship, education, tutoring, schooling, online universities, and other learning services. The Education theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Education Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Protalix Stock Analysis
When running Protalix Biotherapeutics' price analysis, check to measure Protalix Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protalix Biotherapeutics is operating at the current time. Most of Protalix Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Protalix Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protalix Biotherapeutics' price. Additionally, you may evaluate how the addition of Protalix Biotherapeutics to your portfolios can decrease your overall portfolio volatility.